Market Highlights
According to MRFR analysis, Breast Lesion Localization Market is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2027 and is anticipated to reach USD 560 Million by 2027.
The growth of the global breast lesion localization market is driven by various factors, such as the increasing launch of breast lesion localization products and growing numbers of players involved in the development of new breast lesion localization technologies. Some of the key companies operating in this market are B.D. Company, Cook Medical, Endomagnetics Ltd, and others. In addition, the rising awareness program related to breast cancer supports the market growth during the forecasted period.
However, the lack of skilled professionals and the cost of breast lesion localization products may hamper market growth.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/8785
Key Players
Some of the key players in the Global Breast Lesion Localization Market are B.D. Company (US), Cianna Medical (US), Cook Medical (US), Endomagnetics Ltd (UK), Health Beacon (Ireland), Intramedicalimaging, Devicor Medical Products, Inc (US), Somatex Medical Technologies GmbH (Germany), Surgiceye GmbH (Germany) and Ranfac Corporation (US).
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to a large number of men and women affected by breast cancer. The breast lesion localization market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The adaption of a sedentary lifestyle, high consumption of alcohol is leading to cause various types of cancer in which breast cancer holds a high position. It is estimated that 2,620 new cases of breast cancer are anticipated to be diagnosed in men in 2020 in the US. The increasing population affected by breast cancer drives the market growth.
The European breast lesion localization market is the fastest-growing market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing healthcare expenditure, presence of medical device companies, and acceptance of new diagnostic products by diagnostic centers pushing the growth of the regional market. The breast lesion localization market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, rising per capita income, growing healthcare expenditure and awareness towards the diagnosis of breast cancer drives the market to grow at a significant rate during the forecast. The breast lesion localization market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The Global Breast Lesion Localization Market has been segmented based on Type, Technique, Usage, and End Users.
The global breast lesion localization market has been segmented, on the basis of type, into wire-guided localization, radioactive seed localization, non-radioactive radar localization, magnetic seed, and others. The wire-guided localization segment is expected to hold the maximum share of the market throughout the forecast period. The magnetic seed segment is expected to be the fastest-growing during the assessment period. On the basis of technique, the market is segmented into fine-needle aspiration biopsy, core needle biopsy, and image-guided biopsy. Based on usage, the market is segmented into tumor identification and sentinel lymph node identification. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers and diagnostic centers.
Access Report Details @ https://www.marketresearchfuture.com/reports/breast-lesion-localization-market-8785
